サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1125953

インスリンポンプの世界市場 (2022年-2027年)：ユーザー・産業動向・シェア・成長率・インサイト・COVID-19の影響・企業分析

Global Insulin Pump Market, Users, Global Forecast 2022-2027, Industry Trends, Share, Growth, Insight, Impact of COVID-19, Company Analysis
出版日: | 発行: Renub Research | ページ情報: 英文 440 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=155.86円
インスリンポンプの世界市場 (2022年-2027年)：ユーザー・産業動向・シェア・成長率・インサイト・COVID-19の影響・企業分析
出版日: 2022年09月01日
発行: Renub Research
ページ情報: 英文 440 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のインスリンポンプの市場規模は2021年から2027年にかけてCAGR5.20%で推移し、2027年には209億1,000万米ドルの規模に成長すると予測されています。

糖尿病の有病率の上昇や、健康意識の高まりが目立っており、糖尿病は腎不全、脳卒中、麻痺、失明などの他の慢性疾患につながる可能性もあるため、製造業者はインスリンポンプのような適応性と経済性の高い技術の開発に一層注力しています。また、非常に正確なグルコースセンサーや血液モニタリングシステムの開発により、効率的なインスリンポンプに対する需要も高まっています。さらに、最近の市場の拡大は、一人当たりの医療支出の増加やインスリンポンプの機能向上に向けたR&Dの増加といった要因にも助けられています。

当レポートでは、世界のインスリンポンプの市場を調査し、市場概要、市場成長への影響因子の分析、主要製品の差別化ポイント、市場規模 (金額・数量) の推移・予測、主要国別の詳細分析、主要企業のプロファイルなどをまとめています。

目次

第1章 イントロダクション

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場力学

  • 促進要因
  • 課題

第5章 世界のインスリンポンプ市場の分析

  • 市場
  • ユーザー

第6章 世界のインスリンポンプ市場の分析 (数量・金額)

  • 国
  • ユーザーシェア

第7章 患者およびHCPのトレーニングモデル：Medtronic・Insulet Corp・Tandem Diabetes Care

  • Medtronic
  • Insulet Corp
  • Tandem Diabetes Care

第8章 世界で入手可能なインスリンポンプ製品の差別化ポイント

  • Medtronic 530G with Enlite
  • InsuletOmniPod
  • Tandem t:slim
  • Roche Accu-Chek Combo

第9章 米国

  • 糖尿病人口
    • 1型
    • 2型
  • インスリンポンプ市場の分析
    • ユーザー数
    • 市場規模
  • 償還ポリシー

第10章 英国

  • 糖尿病人口
    • 1型
    • 2型
  • インスリンポンプ市場の分析
    • ユーザー数
    • 市場規模
  • 償還ポリシー

第11章 イスラエル

  • 糖尿病人口
    • 1型
    • 2型
  • インスリンポンプ市場の分析
    • ユーザー数
    • 市場規模
  • 償還ポリシー

第12章 ドイツ

  • 糖尿病人口
    • 1型
    • 2型
  • インスリンポンプ市場の分析
    • ユーザー数
    • 市場規模
  • 償還ポリシー

第13章 オランダ

  • 糖尿病人口
    • 1型
    • 2型
  • インスリンポンプ市場の分析
    • ユーザー数
    • 市場規模
  • 償還ポリシー

第14章 スウェーデン

  • 糖尿病人口
    • 1型
    • 2型
  • インスリンポンプ市場の分析
    • ユーザー数
    • 市場規模
  • 償還ポリシー

第15章 フランス

  • 糖尿病人口
    • 1型
    • 2型
  • インスリンポンプ市場の分析
    • ユーザー数
    • 市場規模
  • 償還ポリシー

第16章 スイス

  • 糖尿病人口
    • 1型
    • 2型
  • インスリンポンプ市場の分析
    • ユーザー数
    • 市場規模
  • 償還ポリシー

第17章 オーストラリア

  • 糖尿病人口
    • 1型
    • 2型
  • インスリンポンプ市場の分析
    • ユーザー数
    • 市場規模
  • 償還ポリシー

第18章 日本

  • 糖尿病人口
    • 1型
    • 2型
  • インスリンポンプ市場の分析
    • ユーザー数
    • 市場規模
  • 償還ポリシー

第19章 カナダ

  • 糖尿病人口
    • 1型
    • 2型
  • インスリンポンプ市場の分析
    • ユーザー数
    • 市場規模
  • 償還ポリシー

第20章 クウェート

  • 糖尿病人口
    • 1型
    • 2型
  • インスリンポンプ市場の分析
    • ユーザー数
    • 市場規模
  • 償還ポリシー

第21章 サウジアラビア

  • 糖尿病人口
    • 1型
    • 2型
  • インスリンポンプ市場の分析
    • ユーザー数
    • 市場規模
  • 償還ポリシー

第22章 イタリア

  • 糖尿病人口
    • 1型
    • 2型
  • インスリンポンプ市場の分析
    • ユーザー数
    • 市場規模
  • 償還ポリシー

第23章 スペイン

  • 糖尿病人口
    • 1型
    • 2型
  • インスリンポンプ市場の分析
    • ユーザー数
    • 市場規模
  • 償還ポリシー

第24章 企業分析

  • Medtronic
  • Insulet Corporation
  • Tandem Diabetes Care
  • Roche
図表

List of Figures

  • Figure-01: Global - Insulin Pump Market (Million US$), 2017 - 2021
  • Figure-02: Global - Forecast for Insulin Pump Market (Million US$), 2022 - 2027
  • Figure-03: Global - Insulin Pump User (Thousand), 2017 - 2021
  • Figure-04: Global - Forecast for Insulin Pump User (Thousand), 2022 - 2027
  • Figure-05: United States - Type 1 Diabetes Population (Thousand), 2017 - 2021
  • Figure-06: United States - Forecast for Type 1 Diabetes Population (Thousand), 2022 - 2027
  • Figure-07: United States - Type 2 Diabetes Population (Thousand), 2017 - 2021
  • Figure-08: United States - Forecast for Type 2 Diabetes Population (Thousand), 2022 - 2027
  • Figure-09: United States - Type 1 Insulin Pump User (Thousand), 2017 - 2021
  • Figure-10: United States - Forecast for Type 1 Insulin Pump User (Thousand), 2022 - 2027
  • Figure-11: United States - Type 2 Insulin Pump User (Thousand), 2017 - 2021
  • Figure-12: United States - Forecast for Type 2 Insulin Pump User (Thousand), 2022 - 2027
  • Figure-13: United States - Type 1 Insulin Pump Market (Million US$), 2017 - 2021
  • Figure-14: United States - Forecast for Type 1 Insulin Pump Market (Million US$), 2022 - 2027
  • Figure-15: United States - Type 2 Insulin Pump Market (Million US$), 2017 - 2021
  • Figure-16: United States - Forecast for Type 2 Insulin Pump Market (Million US$), 2022 - 2027
  • Figure-17: United Kingdom - Type 1 Diabetes Population (Thousand), 2017 - 2021
  • Figure-18: United Kingdom - Forecast for Type 1 Diabetes Population (Thousand), 2022 - 2027
  • Figure-19: United Kingdom - Type 2 Diabetes Population (Thousand), 2017 - 2021
  • Figure-20: United Kingdom - Forecast for Type 2 Diabetes Population (Thousand), 2022 - 2027
  • Figure-21: United Kingdom - Type 1 Insulin Pump Users (Thousand), 2017 - 2021
  • Figure-22: United Kingdom - Forecast for Type 1 Insulin Pump Users (Thousand), 2022 - 2027
  • Figure-23: United Kingdom - Type 2 Insulin Pump Users (Thousand), 2017 - 2021
  • Figure-24: United Kingdom - Forecast for Type 2 Insulin Pump Users (Thousand), 2022 - 2027
  • Figure-25: United Kingdom - Type 1 Insulin Pump Market (Million US$), 2017 - 2021
  • Figure-26: United Kingdom - Forecast for Type 1 Insulin Pump Market (Million US$), 2022 - 2027
  • Figure-27: United Kingdom - Type 2 Insulin Pump Market (Million US$), 2017 - 2021
  • Figure-28: United Kingdom - Forecast for Type 2 Insulin Pump Market (Million US$), 2022 - 2027
  • Figure-29: Israel - Type 1 Diabetes Population (Thousand), 2017 - 2021
  • Figure-30: Israel - Forecast for Type 1 Diabetes Population (Thousand), 2022 - 2027
  • Figure-31: Israel - Type 2 Diabetes Population (Thousand), 2017 - 2021
  • Figure-32: Israel - Forecast for Type 2 Diabetes Population (Thousand), 2022 - 2027
  • Figure-33: Israel - Type 1 Insulin Pump Users (Thousand), 2017 - 2021
  • Figure-34: Israel - Forecast for Type 1 Insulin Pump Users (Thousand), 2022 - 2027
  • Figure-35: Israel - Type 2 Insulin Pump Users (Number), 2017 - 2021
  • Figure-36: Israel - Forecast for Type 2 Insulin Pump Users (Number), 2022 - 2027
  • Figure-37: Israel - Type 1 Insulin Pump Market (Million US$), 2017 - 2021
  • Figure-38: Israel - Forecast for Type 1 Insulin Pump Market (Million US$), 2022 - 2027
  • Figure-39: Israel - Type 2 Insulin Pump Market (Million US$), 2017 - 2021
  • Figure-40: Israel - Forecast for Type 2 Insulin Pump Market (Million US$), 2022 - 2027
  • Figure-41: Germany - Type 1 Diabetes Population (Thousand), 2017 - 2021
  • Figure-42: Germany - Forecast for Type 1 Diabetes Population (Thousand), 2022 - 2027
  • Figure-43: Germany - Type 2 Diabetes Population (Thousand), 2017 - 2021
  • Figure-44: Germany - Forecast for Type 2 Diabetes Population (Thousand), 2022 - 2027
  • Figure-45: Germany - Type 1 Insulin Pump Users (Thousand), 2017 - 2021
  • Figure-46: Germany - Forecast for Type 1 Insulin Pump Users (Thousand), 2022 - 2027
  • Figure-47: Germany - Type 2 Insulin Pump Users (Thousand), 2017 - 2021
  • Figure-48: Germany - Forecast for Type 2 Insulin Pump Users (Thousand), 2022 - 2027
  • Figure-49: Germany - Type 1 Insulin Pump Market (Million US$), 2017 - 2021
  • Figure-50: Germany - Forecast for Type 1 Insulin Pump Market (Million US$), 2022 - 2027
  • Figure-51: Germany - Type 2 Insulin Pump Market (Million US$), 2017 - 2021
  • Figure-52: Germany - Forecast for Type 2 Insulin Pump Market (Million US$), 2022 - 2027
  • Figure-53: Netherlands - Type 1 Diabetes Population (Thousand), 2017 - 2021
  • Figure-54: Netherlands - Forecast for Type 1 Diabetes Population (Thousand), 2022 - 2027
  • Figure-55: Netherlands - Type 2 Diabetes Population (Thousand), 2017 - 2021
  • Figure-56: Netherlands - Forecast for Type 2 Diabetes Population (Thousand), 2022 - 2027
  • Figure-57: Netherlands - Type 1 Insulin Pump Users (Thousand), 2017 - 2021
  • Figure-58: Netherlands - Forecast for Type 1 Insulin Pump Users (Thousand), 2022 - 2027
  • Figure-59: Netherlands - Type 2 Insulin Pump Users (Number), 2017 - 2021
  • Figure-60: Netherlands - Forecast for Type 2 Insulin Pump Users (Number), 2022 - 2027
  • Figure-61: Netherlands - Type 1 Insulin Pump Market (Million US$), 2017 - 2021
  • Figure-62: Netherlands - Forecast for Type 1 Insulin Pump Market (Million US$), 2022 - 2027
  • Figure-63: Netherlands - Type 2 Insulin Pump Market (Million US$), 2017 - 2021
  • Figure-64: Netherlands - Forecast for Type 2 Insulin Pump Market (Million US$), 2022 - 2027
  • Figure-65: Sweden - Type 1 Diabetes Population (Thousand), 2017 - 2021
  • Figure-66: Sweden - Forecast for Type 1 Diabetes Population (Thousand), 2022 - 2027
  • Figure-67: Sweden - Type 2 Diabetes Population (Thousand), 2017 - 2021
  • Figure-68: Sweden - Forecast for Type 2 Diabetes Population (Thousand), 2022 - 2027
  • Figure-69: Sweden - Type 1 Insulin Pump Users (Thousand), 2017 - 2021
  • Figure-70: Sweden - Forecast for Type 1 Insulin Pump Users (Thousand), 2022 - 2027
  • Figure-71: Sweden - Type 2 Insulin Pump Users (Number), 2017 - 2021
  • Figure-72: Sweden - Forecast for Type 2 Insulin Pump Users (Number), 2022 - 2027
  • Figure-73: Sweden - Type 1 Insulin Pump Market (Million US$), 2017 - 2021
  • Figure-74: Sweden - Forecast for Type 1 Insulin Pump Market (Million US$), 2022 - 2027
  • Figure-75: Sweden - Type 2 Insulin Pump Market (Million US$), 2017 - 2021
  • Figure-76: Sweden - Forecast for Type 2 Insulin Pump Market (Million US$), 2022 - 2027
  • Figure-77: France - Type 1 Diabetes Population (Thousand), 2017 - 2021
  • Figure-78: France - Forecast for Type 1 Diabetes Population (Thousand), 2022 - 2027
  • Figure-79: France - Type 2 Diabetes Population (Thousand), 2017 - 2021
  • Figure-80: France - Forecast for Type 2 Diabetes Population (Thousand), 2022 - 2027
  • Figure-81: France - Type 1 Insulin Pump Users (Thousand), 2017 - 2021
  • Figure-82: France - Forecast for Type 1 Insulin Pump Users (Thousand), 2022 - 2027
  • Figure-83: France - Type 2 Insulin Pump Users (Thousand), 2017 - 2021
  • Figure-84: France - Forecast for Type 2 Insulin Pump Users (Thousand), 2022 - 2027
  • Figure-85: France - Type 1 Insulin Pump Market (Million US$), 2017 - 2021
  • Figure-86: France - Forecast for Type 1 Insulin Pump Market (Million US$), 2022 - 2027
  • Figure-87: France - Type 2 Insulin Pump Market (Million US$), 2017 - 2021
  • Figure-88: France - Forecast for Type 2 Insulin Pump Market (Million US$), 2022 - 2027
  • Figure-89: Switzerland - Type 1 Diabetes Population (Thousand), 2017 - 2021
  • Figure-90: Switzerland - Forecast for Type 1 Diabetes Population (Thousand), 2022 - 2027
  • Figure-91: Switzerland - Type 2 Diabetes Population (Thousand), 2017 - 2021
  • Figure-92: Switzerland - Forecast for Type 2 Diabetes Population (Thousand), 2022 - 2027
  • Figure-93: Switzerland - Type 1 Insulin Pump Users (Thousand), 2017 - 2021
  • Figure-94: Switzerland - Forecast for Type 1 Insulin Pump Users (Thousand), 2022 - 2027
  • Figure-95: Switzerland - Type 2 Insulin Pump Users (Number), 2017 - 2021
  • Figure-96: Switzerland - Forecast for Type 2 Insulin Pump Users (Number), 2022 - 2027
  • Figure-97: Switzerland - Type 1 Switzerland Insulin Pump Market (Million US$), 2017 - 2021
  • Figure-98: Switzerland - Forecast for Type 1 Switzerland Insulin Pump Market (Million US$), 2022 - 2027
  • Figure-99: Switzerland - Type 2 Switzerland Insulin Pump Market (Million US$), 2017 - 2021
  • Figure-100: Switzerland - Forecast for Type 2 Switzerland Insulin Pump Market (Million US$), 2022 - 2027
  • Figure-101: Australia - Type 1 Diabetes Population (Thousand), 2017 - 2021
  • Figure-102: Australia - Forecast for Type 1 Diabetes Population (Thousand), 2022 - 2027
  • Figure-103: Australia - Type 2 Diabetes Population (Thousand), 2017 - 2021
  • Figure-104: Australia - Forecast for Type 2 Diabetes Population (Thousand), 2022 - 2027
  • Figure-105: Australia - Type 1 Insulin Pump Users (Thousand), 2017 - 2021
  • Figure-106: Australia - Forecast for Type 1 Insulin Pump Users (Thousand), 2022 - 2027
  • Figure-107: Australia - Type 2 Insulin Pump Users (Number), 2017 - 2021
  • Figure-108: Australia - Forecast for Type 2 Insulin Pump Users (Number), 2022 - 2027
  • Figure-109: Australia - Type 1 Insulin Pump Market (Million US$), 2017 - 2021
  • Figure-110: Australia - Forecast for Type 1 Insulin Pump Market (Million US$), 2022 - 2027
  • Figure-111: Australia - Type 2 Insulin Pump Market (Million US$), 2017 - 2021
  • Figure-112: Australia - Forecast for Type 2 Insulin Pump Market (Million US$), 2022 - 2027
  • Figure-113: Japan - Type 1 Diabetes Population (Thousand), 2017 - 2021
  • Figure-114: Japan - Forecast for Type 1 Diabetes Population (Thousand), 2022 - 2027
  • Figure-115: Japan - Type 2 Diabetes Population (Thousand), 2017 - 2021
  • Figure-116: Japan - Forecast for Type 2 Diabetes Population (Thousand), 2022 - 2027
  • Figure-117: Japan - Type 1 Insulin Pump Users (Thousand), 2017 - 2021
  • Figure-118: Japan - Forecast for Type 1 Insulin Pump Users (Thousand), 2022 - 2027
  • Figure-119: Japan - Type 2 Insulin Pump Users (Thousand), 2017 - 2021
  • Figure-120: Japan - Forecast for Type 2 Insulin Pump Users (Thousand), 2022 - 2027
  • Figure-121: Japan - Type 1 Insulin Pump Market (Million US$), 2017 - 2021
  • Figure-122: Japan - Forecast for Type 1 Insulin Pump Market (Million US$), 2022 - 2027
  • Figure-123: Japan - Type 2 Insulin Pump Market (Million US$), 2017 - 2021
  • Figure-124: Japan - Forecast for Type 2 Insulin Pump Market (Million US$), 2022 - 2027
  • Figure-125: Canada - Type 1 Diabetes Population (Thousand), 2017 - 2021
  • Figure-126: Canada - Forecast for Type 1 Diabetes Population (Thousand), 2022 - 2027
  • Figure-127: Canada - Type 2 Diabetes Population (Thousand), 2017 - 2021
  • Figure-128: Canada - Forecast for Type 2 Diabetes Population (Thousand), 2022 - 2027
  • Figure-129: Canada - Type 1 Insulin Pump Users (Thousand), 2017 - 2021
  • Figure-130: Canada - Forecast for Type 1 Insulin Pump Users (Thousand), 2022 - 2027
  • Figure-131: Canada - Type 2 Insulin Pump Users (Thousand), 2017 - 2021
  • Figure-132: Canada - Forecast for Type 2 Insulin Pump Users (Thousand), 2022 - 2027
  • Figure-133: Canada - Type 1 Insulin Pump Market (Million US$), 2017 - 2021
  • Figure-134: Canada - Forecast for Type 1 Insulin Pump Market (Million US$), 2022 - 2027
  • Figure-135: Canada - Type 2 Insulin Pump Market (Million US$), 2017 - 2021
  • Figure-136: Canada - Forecast for Type 2 Insulin Pump Market (Million US$), 2022 - 2027
  • Figure-137: Kuwait - Type 1 Diabetes Population (Thousand), 2017 - 2021
  • Figure-138: Kuwait - Forecast for Type 1 Diabetes Population (Thousand), 2022 - 2027
  • Figure-139: Kuwait - Type 2 Diabetes Population (Thousand), 2017 - 2021
  • Figure-140: Kuwait - Forecast for Type 2 Diabetes Population (Thousand), 2022 - 2027
  • Figure-141: Kuwait - Type 1 Insulin Pump Users (Number), 2017 - 2021
  • Figure-142: Kuwait - Forecast for Type 1 Insulin Pump Users (Number), 2022 - 2027
  • Figure-143: Kuwait - Type 2 Insulin Pump Users (Number), 2017 - 2021
  • Figure-144: Kuwait - Forecast for Type 2 Insulin Pump Users (Number), 2022 - 2027
  • Figure-145: Kuwait - Type 1 Insulin Pump Market (Million US$), 2017 - 2021
  • Figure-146: Kuwait - Forecast for Type 1 Insulin Pump Market (Million US$), 2022 - 2027
  • Figure-147: Kuwait - Type 2 Insulin Pump Market (Million US$), 2017 - 2021
  • Figure-148: Kuwait - Forecast for Type 2 Insulin Pump Market (Million US$), 2022 - 2027
  • Figure-149: Saudi Arabia - Type 1 Diabetes Population (Thousand), 2017 - 2021
  • Figure-150: Saudi Arabia - Forecast for Type 1 Diabetes Population (Thousand), 2022 - 2027
  • Figure-151: Saudi Arabia - Type 2 Diabetes Population (Thousand), 2017 - 2021
  • Figure-152: Saudi Arabia - Forecast for Type 2 Diabetes Population (Thousand), 2022 - 2027
  • Figure-153: Saudi Arabia - Type 1 Insulin Pump Users (Thousand), 2017 - 2021
  • Figure-154: Saudi Arabia - Forecast for Type 1 Insulin Pump Users (Thousand), 2022 - 2027
  • Figure-155: Saudi Arabia - Type 2 Insulin Pump Users (Thousand), 2017 - 2021
  • Figure-156: Saudi Arabia - Forecast for Type 2 Insulin Pump Users (Thousand), 2022 - 2027
  • Figure-157: Saudi Arabia - Type 1 Insulin Pump Market (Million US$), 2017 - 2021
  • Figure-158: Saudi Arabia - Forecast for Type 1 Insulin Pump Market (Million US$), 2022 - 2027
  • Figure-159: Saudi Arabia - Type 2 Insulin Pump Market (Million US$), 2017 - 2021
  • Figure-160: Saudi Arabia - Forecast for Type 2 Insulin Pump Market (Million US$), 2022 - 2027
  • Figure-161: Italy - Type 1 Diabetes Population (Thousand), 2017 - 2021
  • Figure-162: Italy - Forecast for Type 1 Diabetes Population (Thousand), 2022 - 2027
  • Figure-163: Italy - Type 2 Diabetes Population (Thousand), 2017 - 2021
  • Figure-164: Italy - Forecast for Type 2 Diabetes Population (Thousand), 2022 - 2027
  • Figure-165: Italy - Type 1 Insulin Pump Users (Thousand), 2017 - 2021
  • Figure-166: Italy - Forecast for Type 1 Insulin Pump Users (Thousand), 2022 - 2027
  • Figure-167: Italy - Type 2 Insulin Pump Users (Thousand), 2017 - 2021
  • Figure-168: Italy - Forecast for Type 2 Insulin Pump Users (Thousand), 2022 - 2027
  • Figure-169: Italy - Type 1 Insulin Pump Market (Million US$), 2017 - 2021
  • Figure-170: Italy - Forecast for Type 1 Insulin Pump Market (Million US$), 2022 - 2027
  • Figure-171: Italy - Type 2 Insulin Pump Market (Million US$), 2017 - 2021
  • Figure-172: Italy - Forecast for Type 2 Insulin Pump Market (Million US$), 2022 - 2027
  • Figure-173: Spain - Type 1 Diabetes Population (Thousand), 2017 - 2021
  • Figure-174: Spain - Forecast for Type 1 Diabetes Population (Thousand), 2022 - 2027
  • Figure-175: Spain - Type 2 Diabetes Population (Thousand), 2017 - 2021
  • Figure-176: Spain - Forecast for Type 2 Diabetes Population (Thousand), 2022 - 2027
  • Figure-177: Spain - Type 1 Insulin Pump Users (Thousand), 2017 - 2021
  • Figure-178: Spain - Forecast for Type 1 Insulin Pump Users (Thousand), 2022 - 2027
  • Figure-179: Spain - Type 2 Insulin Pump Users (Thousand), 2017 - 2021
  • Figure-180: Spain - Forecast for Type 2 Insulin Pump Users (Thousand), 2022 - 2027
  • Figure-181: Spain - Type 1 Insulin Pump Market (Million US$), 2017 - 2021
  • Figure-182: Spain - Forecast for Type 1 Insulin Pump Market (Million US$), 2022 - 2027
  • Figure-183: Spain - Type 2 Insulin Pump Market (Million US$), 2017 - 2021
  • Figure-184: Spain - Forecast for Type 2 Insulin Pump Market (Million US$), 2022 - 2027
  • Figure-185: Medtronic - Global Revenue Market (Million US$), 2017 - 2021
  • Figure-186: Medtronic - Forecast for Global Revenue Market (Million US$), 2022 - 2027
  • Figure-187: Insulet Corporation - Global Revenue Market (Million US$), 2017 - 2021
  • Figure-188: Insulet Corporation - Forecast for Global Revenue Market (Million US$), 2022 - 2027
  • Figure-189: Tandem Diabetes Care - Global Revenue Market (Million US$), 2017 - 2021
  • Figure-190: Tandem Diabetes Care - Forecast for Global Revenue Market (Million US$), 2022 - 2027
  • Figure-191: Roche - Global Revenue Market (Million US$), 2017 - 2021
  • Figure-192: Roche - Forecast for Global Revenue Market (Million US$), 2022 - 2027

List of Tables

  • Table-01: Global - Insulin Pump Market Share by Country (Percentage), 2017 - 2021
  • Table-02: Global - Forecast for Insulin Pump Market Share by Country (Percentage), 2022 - 2027
  • Table-03: Global - Insulin Pump Volume Share by Country (Percentage), 2017 - 2021
  • Table-04: Global - Forecast for Insulin Pump Volume Share by Country (Percentage), 2022 - 2027
目次

According to Renub Research, Global Insulin Pump Market is estimated to reach US$ 20.91 Billion by 2027. Insulin pumps are compact electronic medical devices that can be fastened to a belt, hidden in a pocket, or worn under clothing. Besides, to regulate the rise in blood glucose levels, the pump delivers controlled quantities of insulin into the body at regular intervals, based on the consumer's basal and bolus rates. Furthermore, it works with a needle and a flexible catheter to inject insulin straight into the fatty tissue, subsequently taped and fastened. In addition, insulin pumps help people with type 1 and type 2 diabetes by giving them more food options and eating schedule flexibility and reducing the number of injections they need.

Global Insulin Pump Market Size Is Expanding with a CAGR Of 5.20% During 2021-2027:

The rising prevalence of diabetes and increased health awareness have been prevalent. Furthermore, because diabetes can lead to other chronic illnesses, including kidney failure, stroke, paralysis, and blindness, manufacturers focus more on developing adaptable and economical technologies like insulin pumps. The demand for efficient insulin pumps has also increased due to the development of very accurate glucose sensors and blood monitoring systems. Furthermore, recent market expansion has been aided by factors such as rising per capita healthcare spending and increased research and development for improving the functionality of insulin pumps.

COVID-19 Impact Analysis on Global Insulin Pump Industry:

According to the IDF, diabetic people were more likely to get COVID-19 disease and experience severe symptoms. As a result, during the COVID-19 pandemic, demand for insulin pumps for at-home use skyrocketed. As a result of the epidemic, the homecare insulin pump business exploded worldwide. Moreover, demand for automated and efficient insulin pumps skyrocketed during the epidemic. Moreover, as per our analysis, Global Insulin Pump Market was US$ 15.43 Billion in 2021.

Segment Analysis in Global Insulin Pump Market:

In our report, the Global Global Insulin Pump Market is studied for the market in the United States, United Kingdom, Israel, Germany, Netherlands, Sweden, France, Switzerland, Australia, Japan, Canada, Kuwait, Saudi Arabia, and Italy and Spain. Further, the market in detail is categorized based on Diabetes Population (Type 1 and Type 2), Insulin Pump Market Analysis (Insulin Pump User (Type 1 and Type 2) & Insulin Pump Market (Type 1 and Type 2)), and Reimbursement Policies on Insulin Pump.

Competitive Landscape:

The Global Insulin Pump Market is highly competitive, competing with only a few companies. Medtronic, Insulet Corporation, Tandem Diabetes Care, and Roche are the critical players profiled in our analysis. These companies control a large percentage of the worldwide market. In addition, they are constantly expanding into new markets to generate new revenue streams and enhance old ones. The acts of these market participants will create a competitive environment, forcing businesses to experiment with the latest technology to keep their products unique. Companies are also collaborating to expand their technological understanding and reduce the time it takes to develop a product.

Renub Research latest report "Global Insulin Pump Market, Global Forecast, By Differentiation Points, Products (Medtronic 530G with Enlite, InsuletOmniPod, Tandem t:slim and Roche Accu-Chek Combo), By Countries (United States, United Kingdom, Israel, Germany, Netherlands, Sweden, France, Switzerland, Australia, Japan, Canada, Kuwait, Saudi Arabia, Italy and Spain), Country Insights (Diabetes Population (Type 1 and Type 2), Insulin Pump Market Analysis (Insulin Pump User (Type 1 and Type 2) & Insulin Pump Market (Type 1 and Type 2)) and Reimbursement Policies on Insulin Pump), Companies (Medtronic, Insulet Corporation, Tandem Diabetes Care and Roche)" provides a detailed analysis of Global Insulin Pump Industry.

The above-mentioned countries have been covered from 3 viewpoints:

1. Diabetes Population

  • Type 1
  • Type 2

2. Insulin Pump Analysis

  • Insulin Pump User (Type 1 and Type 2)
  • Insulin Pump Market (Type 1 and Type 2)

3. Reimbursement Policies on Insulin Pump

Countries - Insulin Pump Market & Users, Diabetes Type 1 & 2 Population of all the 15 Countries Covered in the Report

1. United States

2. United Kingdom

3. Israel

4. Germany

5. Netherlands

6. Sweden

7. France

8. Switzerland

9. Australia

10. Japan

11. Canada

12. Kuwait

13. Saudi Arabia

14. Italy

15. Spain

Differentiation Points, Products Available Worldwide have been covered from 4 viewpoints:

1. Medtronic 530G with Enlite

2. InsuletOmniPod

3. Tandem t:slim

4. Roche Accu-Chek Combo

Company Insights:

  • Overview
  • Recent Development
  • Revenue

Companies Covered:

1. Medtronic

2. Insulet Corporation

3. Tandem Diabetes Care

4. Roche

Table of Contents

1. Introduction

2. Research Methodology

3. Executive Summary

4. Market Dynamics

  • 4.1 Growth Drivers
  • 4.2 Challenges

5. Global Insulin Pump Analysis

  • 5.1 Market
  • 5.2 User

6. Global Insulin Pump Market & Volume Share Analysis

  • 6.1 Country
  • 6.2 User Share

7. Training Model for Patients & HCP - of Medtronic, Insulet Corp & Tandem Diabetes Care

  • 7.1 Medtronic
    • 7.1.1 Training Guidelines for Insulin Pump Therapy to New Patients
    • 7.1.2 Training Model for HCP (HealthCare Professional)
  • 7.2 Insulet Corporation
    • 7.2.1 Training Structure for New Patients - Insulet Corporation
  • 7.3 Tandem Diabetes Care

8. Differentiation Points of Insulin Pump Products Available Worldwide

  • 8.1 Medtronic 530G with Enlite
  • 8.2 InsuletOmniPod
  • 8.3 Tandem t:slim
  • 8.4 Roche Accu-Chek Combo

9. United States

  • 9.1 Diabetes Population
    • 9.1.1 Type 1
    • 9.1.2 Type 2
  • 9.2 United States - Insulin Pump Market Analysis
    • 9.2.1 Insulin Pump User
      • 9.2.1.1 Type 1
      • 9.2.1.2 Type 2
    • 9.2.2 Insulin Pump Market
      • 9.2.2.1 Type 1
      • 9.2.2.2 Type 2
  • 9.3 Reimbursement Policies on Insulin Pump

10. United Kingdom

  • 10.1 Diabetes Population
    • 10.1.1 Type 1
    • 10.1.2 Type 2
  • 10.2 Insulin Pump Analysis
    • 10.2.1 Insulin Pump Users
      • 10.2.1.1 Type 1
      • 10.2.1.2 Type 2
    • 10.2.2 Insulin Pump Market
      • 10.2.2.1 Type 1
      • 10.2.2.2 Type 2
  • 10.3 Reimbursement Policies on Insulin Pump

11. Israel

  • 11.1 Diabetes Population
    • 11.1.1 Type 1
    • 11.1.2 Type 2
  • 11.2 Insulin Pump Analysis
    • 11.2.1 Insulin Pump Users
      • 11.2.1.1 Type 1
      • 11.2.1.2 Type 2
    • 11.2.2 Insulin Pump Market
      • 11.2.2.1 Type 1
      • 11.2.2.2 Type 2
  • 11.3 Reimbursement Policies on Insulin Pump

12. Germany

  • 12.1 Diabetes Population
    • 12.1.1 Type 1
    • 12.1.2 Type 2
  • 12.2 Insulin Pump Analysis
    • 12.2.1 Insulin Pump Users
      • 12.2.1.1 Type 1
      • 12.2.1.2 Type 2
    • 12.2.2 Insulin Pump Market
      • 12.2.2.1 Type 1
      • 12.2.2.2 Type 2
  • 12.3 Reimbursement Policies on Insulin Pump

13. Netherlands

  • 13.1 Diabetes Population
    • 13.1.1 Type 1
    • 13.1.2 Type 2
  • 13.2 Insulin Pump Analysis
    • 13.2.1 Insulin Pump Users
      • 13.2.1.1 Type 1
      • 13.2.1.2 Type 2
    • 13.2.2 Insulin Pump Market
      • 13.2.2.1 Type 1
      • 13.2.2.2 Type 2
  • 13.3 Reimbursement Policies on Insulin Pump

14. Sweden

  • 14.1 Diabetes Population
    • 14.1.1 Type 1
    • 14.1.2 Type 2
  • 14.2 Insulin Pump Analysis
    • 14.2.1 Insulin Pump Users
      • 14.2.1.1 Type 1
      • 14.2.1.2 Type 2
    • 14.2.2 Insulin Pump Market
      • 14.2.2.1 Type 1
      • 14.2.2.2 Type 2
  • 14.3 Reimbursement Policies on Insulin Pump

15. France

  • 15.1 Diabetes Population
    • 15.1.1 Type 1
    • 15.1.2 Type 2
  • 15.2 Insulin Pump Analysis
    • 15.2.1 Insulin Pump Users
      • 15.2.1.1 Type 1
      • 15.2.1.2 Type 2
    • 15.2.2 Insulin Pump Market
      • 15.2.2.1 Type 1
      • 15.2.2.2 Type 2
  • 15.3 Reimbursement Policies on Insulin Pump

16. Switzerland

  • 16.1 Diabetes Population
    • 16.1.1 Type 1
    • 16.1.2 Type 2
  • 16.2 Insulin Pump Analysis
    • 16.2.1 Insulin Pump Users
      • 16.2.1.1 Type 1
      • 16.2.1.2 Type 2
    • 16.2.2 Switzerland Insulin Pump Market
      • 16.2.2.1 Type 1
      • 16.2.2.2 Type 2
  • 16.3 Reimbursement Policies on Insulin Pump

17. Australia

  • 17.1 Diabetes Population
    • 17.1.1 Type 1
    • 17.1.2 Type 2
  • 17.2 Insulin Pump Analysis
    • 17.2.1 Insulin Pump Users
      • 17.2.1.1 Type 1
      • 17.2.1.2 Type 2
    • 17.2.2 Insulin Pump Market
      • 17.2.2.1 Type 1
      • 17.2.2.2 Type 2
  • 17.3 Reimbursement Policies on Insulin Pump

18. Japan

  • 18.1 Diabetes Population
    • 18.1.1 Type 1
    • 18.1.2 Type 2
  • 18.2 Insulin Pump Analysis
    • 18.2.1 Insulin Pump Users
      • 18.2.1.1 Type 1
      • 18.2.1.2 Type 2
    • 18.2.2 Insulin Pump Market
      • 18.2.2.1 Type 1
      • 18.2.2.2 Type 2
  • 18.3 Reimbursement Policies on Insulin Pump

19. Canada

  • 19.1 Diabetes Population
    • 19.1.1 Type 1
    • 19.1.2 Type 2
  • 19.2 Insulin Pump Analysis
    • 19.2.1 Insulin Pump Users
      • 19.2.1.1 Type 1
      • 19.2.1.2 Type 2
    • 19.2.2 Insulin Pump Market
      • 19.2.2.1 Type 1
      • 19.2.2.2 Type 2
  • 19.3 Reimbursement Policies on Insulin Pump

20. Kuwait

  • 20.1 Diabetes Population
    • 20.1.1 Type 1
    • 20.1.2 Type 2
  • 20.2 Insulin Pump Analysis
    • 20.2.1 Insulin Pump Users
      • 20.2.1.1 Type 1
      • 20.2.1.2 Type 2
    • 20.2.2 Insulin Pump Market
      • 20.2.2.1 Type 1
      • 20.2.2.2 Type 2
  • 20.3 Reimbursement Policies on Insulin Pump

21. Saudi Arabia

  • 21.1 Diabetes Population
    • 21.1.1 Type 1
    • 21.1.2 Type 2
  • 21.2 Insulin Pump Analysis
    • 21.2.1 Insulin Pump Users
      • 21.2.1.1 Type 1
      • 21.2.1.2 Type 2
    • 21.2.2 Insulin Pump Market
      • 21.2.2.1 Type 1
      • 21.2.2.2 Type 2
  • 21.3 Reimbursement Policies on Insulin Pump

22. Italy

  • 22.1 Diabetes Population
    • 22.1.1 Type 1
    • 22.1.2 Type 2
  • 22.2 Insulin Pump Analysis
    • 22.2.1 Insulin Pump Users
      • 22.2.1.1 Type 1
      • 22.2.1.2 Type 2
    • 22.2.2 Insulin Pump Market
      • 22.2.2.1 Type 1
      • 22.2.2.2 Type 2
  • 22.3 Reimbursement Policies on Insulin Pump

23. Spain

  • 23.1 Diabetes Population
    • 23.1.1 Type 1
    • 23.1.2 Type 2
  • 23.2 Insulin Pump Analysis
    • 23.2.1 Insulin Pump Users
      • 23.2.1.1 Type 1
      • 23.2.1.2 Type 2
    • 23.2.2 Insulin Pump Market
      • 23.2.2.1 Type 1
      • 23.2.2.2 Type 2
  • 23.3 Reimbursement Policies on Insulin Pump

24. Company Analysis

  • 24.1 Medtronic
    • 24.1.1 Overview
    • 24.1.2 Recent Development
    • 24.1.3 Revenue
  • 24.2 Insulet Corporation
    • 24.2.1 Overview
    • 24.2.2 Recent Development
    • 24.2.3 Revenue
  • 24.3 Tandem Diabetes Care
    • 24.3.1 Overview
    • 24.3.2 Recent Development
    • 24.3.3 Revenue
  • 24.4 Roche
    • 24.4.1 Overview
    • 24.4.2 Recent Development
    • 24.4.3 Revenue